The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex

被引:171
作者
He, Yupeng [1 ]
Selvaraju, Sujatha [1 ]
Curtin, Michael L. [1 ]
Jakob, Clarissa G. [1 ]
Zhu, Haizhong [1 ]
Comess, Kenneth M. [1 ]
Shaw, Bailin [1 ]
The, Juliana [2 ]
Lima-Fernandes, Evelyne [2 ,3 ,4 ]
Szewczyk, Magdalena M. [2 ]
Cheng, Dong [1 ]
Klinge, Kelly L. [1 ]
Li, Huan-Qiu [1 ]
Pliushchev, Marina [1 ]
Algire, Mikkel A. [1 ]
Maag, David [1 ]
Guo, Jun [1 ]
Dietrich, Justin [1 ]
Panchal, Sanjay C. [1 ]
Petros, Andrew M. [1 ]
Sweis, Ramzi F. [1 ]
Torrent, Maricel [1 ]
Bigelow, Lance J. [1 ]
Senisterra, Guillermo [2 ]
Li, Fengling [2 ]
Kennedy, Steven [2 ]
Wu, Qin [2 ,3 ,4 ]
Osterling, Donald J. [1 ]
Lindley, David J. [1 ]
Gao, Wenqing [1 ]
Galasinski, Scott [1 ]
Barsyte-Lovejoy, Dalia [2 ]
Vedadi, Masoud [2 ,5 ]
Buchanan, Fritz G. [1 ]
Arrowsmith, Cheryl H. [2 ,3 ,4 ]
Chiang, Gary G. [1 ,6 ]
Sun, Chaohong [1 ]
Pappano, William N. [1 ]
机构
[1] AbbVie Inc, N Chicago, IL 60064 USA
[2] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[5] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[6] eFFECTOR Therapeut, San Diego, CA USA
基金
巴西圣保罗研究基金会; 加拿大健康研究院; 加拿大创新基金会; 英国惠康基金;
关键词
POLYCOMB REPRESSIVE COMPLEX; B-CELL LYMPHOMA; THERMAL SHIFT ASSAYS; HISTONE H3; DRUG DISCOVERY; LYSINE; 27; METHYLTRANSFERASE ACTIVITY; SELECTIVE INHIBITOR; H3K27; METHYLATION; EZH2; INHIBITION;
D O I
10.1038/nchembio.2306
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polycomb repressive complex 2 (PRC2) is a regulator of epigenetic states required for development and homeostasis. PRC2 trimethylates histone H3 at lysine 27 (H3K27me3), which leads to gene silencing, and is dysregulated in many cancers. The embryonic ectoderm development (EED) protein is an essential subunit of PRC2 that has both a scaffolding function and an H3K27me3-binding function. Here we report the identification of A-395, a potent antagonist of the H3K27me3 binding functions of EED. Structural studies demonstrate that A-395 binds to EED in the H3K27me3-binding pocket, thereby preventing allosteric activation of the catalytic activity of PRC2. Phenotypic effects observed in vitro and in vivo are similar to those of known PRC2 enzymatic inhibitors; however, A-395 retains potent activity against cell lines resistant to the catalytic inhibitors. A-395 represents a first-in-class antagonist of PRC2 protein-protein interactions (PPI) for use as a chemical probe to investigate the roles of EED-containing protein complexes.
引用
收藏
页码:389 / +
页数:10
相关论文
共 56 条
[1]   Epigenetic protein families: a new frontier for drug discovery [J].
Arrowsmith, Cheryl H. ;
Bountra, Chas ;
Fish, Paul V. ;
Lee, Kevin ;
Schapira, Matthieu .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (05) :384-400
[2]   Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitors [J].
Baker, Theresa ;
Nerle, Sujata ;
Pritchard, Justin ;
Zhao, Boyang ;
Rivera, Victor M. ;
Garner, Andrew ;
Gonzalvez, Francois .
ONCOTARGET, 2015, 6 (32) :32646-32655
[3]   (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells [J].
Barsyte-Lovejoy, Dalia ;
Li, Fengling ;
Oudhoff, Menno J. ;
Tatlock, John H. ;
Dong, Aiping ;
Zeng, Hong ;
Wu, Hong ;
Freeman, Spencer A. ;
Schapira, Matthieu ;
Senisterra, Guillermo A. ;
Kuznetsova, Ekaterina ;
Marcellus, Richard ;
Allali-Hassani, Abdellah ;
Kennedy, Steven ;
Lambert, Jean-Philippe ;
Couzens, Amber L. ;
Aman, Ahmed ;
Gingras, Anne-Claude ;
Al-Awar, Rima ;
Fish, Paul V. ;
Gerstenberger, Brian S. ;
Roberts, Lee ;
Benn, Caroline L. ;
Grimley, Rachel L. ;
Braam, Mitchell J. S. ;
Rossi, Fabio M. V. ;
Sudol, Marius ;
Brown, Peter J. ;
Bunnage, Mark E. ;
Owen, Dafydd R. ;
Zaph, Colby ;
Vedadi, Masoud ;
Arrowsmith, Cheryl H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (35) :12853-12858
[4]   Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance [J].
Brooun, Alexei ;
Gajiwala, Ketan S. ;
Deng, Ya-Li ;
Liu, Wei ;
Bolanos, Ben ;
Bingham, Patrick ;
He, You-Ai ;
Diehl, Wade ;
Grable, Nicole ;
Kung, Pei-Pei ;
Sutton, Scott ;
Maegley, Karen A. ;
Yu, Xiu ;
Stewart, Al E. .
NATURE COMMUNICATIONS, 2016, 7 :11384
[5]   The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface [J].
Camerino, Michelle A. ;
Zhong, Nan ;
Dong, Aiping ;
Dickson, Bradley M. ;
James, Lindsey I. ;
Baughman, Brandi M. ;
Norris, Jacqueline L. ;
Kireev, Dmitri B. ;
Janzen, William P. ;
Arrowsmith, Cheryl H. ;
Frye, Stephen V. .
MEDCHEMCOMM, 2013, 4 (11) :1501-1507
[6]   Role of histone H3 lysine 27 methylation in polycomb-group silencing [J].
Cao, R ;
Wang, LJ ;
Wang, HB ;
Xia, L ;
Erdjument-Bromage, H ;
Tempst, P ;
Jones, RS ;
Zhang, Y .
SCIENCE, 2002, 298 (5595) :1039-1043
[7]   Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing [J].
Cao, R ;
Tsukada, Y ;
Zhang, Y .
MOLECULAR CELL, 2005, 20 (06) :845-854
[8]   The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression [J].
Chan, Kui-Ming ;
Fang, Dong ;
Gan, Haiyun ;
Hashizume, Rintaro ;
Yu, Chuanhe ;
Schroeder, Mark ;
Gupta, Nalin ;
Mueller, Sabine ;
James, C. David ;
Jenkins, Robert ;
Sarkaria, Jann ;
Zhang, Zhiguo .
GENES & DEVELOPMENT, 2013, 27 (09) :985-990
[9]   Molecular recognition of histone H3 by the WD40 protein WDR5 [J].
Couture, Jean-Francois ;
Collazo, Evys ;
Trievel, Raymond C. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (08) :698-703
[10]   Transcriptional regulation by Polycomb group proteins [J].
Di Croce, Luciano ;
Helin, Kristian .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2013, 20 (10) :1147-1155